Instituto de Ciencias de la Salud, Universidad Autónoma del Estado de Hidalgo, Km. 4.5 Carretera Pachuca-Tulancingo, Unidad Universitaria, CP 42076 Pachuca, Hidalgo, Mexico.
J Ethnopharmacol. 2012 Sep 28;143(2):716-9. doi: 10.1016/j.jep.2012.07.039. Epub 2012 Aug 4.
Chiranthodendron pentadactylon Larreat is frequently used in Mexican traditional medicine as well as in Guatemalan for several medicinal purposes, including their use in the control of diarrhea.
This work was undertaken to obtain additional information that support the traditional use of Chiranthodendron pentadactylon Larreat, on pharmacological basis using the major antisecretory isolated compound from computational, in vitro and in vivo experiments.
(-)-Epicatechin was isolated from ethyl acetate fraction of the plant crude extract. In vivo toxin (Vibrio cholera or Escherichia coli)-induced intestinal secretion in rat jejunal loops models and sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis on Vibrio cholera toxin were used in experimental studies while the molecular docking technique was used to conduct computational study.
The antisecretory activity of epicatechin was tested against Vibrio cholera and Escherichia coli toxins at oral dose 10 mg/kg in the rat model. It exhibited the most potent activity on Vibrio cholera toxin (56.9% of inhibition). In the case of Escherichia coli toxin its effect was moderate (24.1% of inhibition). SDS-PAGE analysis revealed that both (-)-epicatechin and Chiranthodendron pentadactylon extract interacted with the Vibrio cholera toxin at concentration from 80 μg/mL and 300 μg/mL, respectively. Computational molecular docking showed that epicatechin interacted with four amino acid residues (Asn 103, Phe 31, Phe 223 and The 78) in the catalytic site of Vibrio cholera toxin, revealing its potential binding mode at molecular level.
The results derived from computational, in vitro and in vivo experiments on Vibrio cholera and Escherichia coli toxins confirm the potential of epicatechin as a new antisecretory compound and give additional scientific support to anecdotal use of Chiranthodendron pentadactylon Larreat in Mexican traditional medicine to treat gastrointestinal disorders such as diarrhea.
Chiranthodendron pentadactylon Larreat 在墨西哥传统医学中以及危地马拉被广泛用于多种药用目的,包括控制腹泻。
这项工作旨在获得更多信息,以支持 Chiranthodendron pentadactylon Larreat 的传统用途,基于使用从计算、体外和体内实验中分离得到的主要抗分泌化合物的药理学基础。
(-)-表儿茶素从植物粗提取物的乙酸乙酯部分中分离得到。在体内毒素(霍乱弧菌或大肠杆菌)诱导的大鼠空肠环模型中的肠分泌和霍乱弧菌毒素的十二烷基硫酸钠-聚丙烯酰胺凝胶电泳(SDS-PAGE)分析用于实验研究,而分子对接技术用于进行计算研究。
儿茶素的抗分泌活性在大鼠模型中以 10mg/kg 的口服剂量针对霍乱弧菌和大肠杆菌毒素进行了测试。它对霍乱弧菌毒素(56.9%的抑制)表现出最强的活性。在大肠杆菌毒素的情况下,其作用适中(24.1%的抑制)。SDS-PAGE 分析表明,(-)-表儿茶素和 Chiranthodendron pentadactylon 提取物均与霍乱弧菌毒素在 80μg/mL 和 300μg/mL 的浓度下相互作用,分别。计算分子对接表明,表儿茶素与霍乱弧菌毒素催化部位的四个氨基酸残基(Asn 103、Phe 31、Phe 223 和 The 78)相互作用,揭示了其在分子水平上的潜在结合模式。
基于霍乱弧菌和大肠杆菌毒素的计算、体外和体内实验的结果,证实了表儿茶素作为一种新的抗分泌化合物的潜力,并为 Chiranthodendron pentadactylon Larreat 在墨西哥传统医学中用于治疗腹泻等胃肠道疾病的轶事用途提供了额外的科学支持。